Institutional HoldersBeta

Who holds a company, from every 13F filed for the quarter, one row per filer exactly as filed, against the latest share count the company reported.

BioNexus Gene Lab Corp

CIK 0001737523BGLC· quarter ending 2026-06-30

Shares outstanding

2,933,442

as of 2026-08-14 · 10-Q cover page, filed 2026-08-14

Held by 13F filers

14,385

0.5% of shares outstanding

Holders

+1 vs 2026-03-31 · 2 new, 1 exited

Value

$27K

shares +6100.4% vs prior quarter

Share classes (cover page of the 10-Q filed 2026-08-14, as of 2026-08-14)

Class	Listed	Shares outstanding	Held by 13F filers	% of class	Holders	CUSIP
Common stock	BGLC · NASDAQ	2,933,442	14,385	0.5%	3	090628306

Each class is compared with its own share count; classes are not added together. A class that is not exchange-listed cannot be held by 13F filers.

Securities (CUSIPs held in 13F this quarter)

tick to combine

Count	CUSIP	Class (as filers write it)	Holders	Shares held	Class shares	% of class	Value	Options	Mapped via
	090628306	COM	3	14,385	2,933,442	0.5%	$27K	—	13DG	holders →

Totals combine the ticked CUSIPs and update as you tick: common-stock classes by default; preferreds, notes, warrants and depositary shares are listed but not counted. "holders →" shows a single CUSIP on its own. Bonds are held as a principal amount, not shares. Options positions are never counted as holdings. 1 further CUSIPs map to this company (mostly bonds) but no 13F filer held them this quarter.

Top holders (3 of 3 · 090628306)

change vs 2026-03-31

#	Filer	Shares	% of class	Value	Change
1	HRT FINANCIAL LP	14,283	0.49%	$27K	NEW
2	UBS Group AG	101	0.00%	$197	-130 (-56.3%)
3	Caitong International Asset Management Co., Ltd	1	0.00%	$2	NEW

Exited since 2026-03-31 (1 filers; largest 1 shown)

WELLS FARGO & COMPANY/MN

−1

Large holders from 13D/13G (latest per reporting person, last 2 years)

Filed when a holder crosses 5% or changes materially, so often more current than the quarter-end 13F. Percentages are the filer's own, against the share count they used.

Reporting person	Form	Filed	Event	Shares	% of class
Tan Lee Su-Leng	SCHEDULE 13D	2026-08-14	2026-08-13	338,709	11.5%

Source: SEC Form 13F-HR information tables for the quarter ending 2026-06-30 (filed within 45 days of quarter end; amendments applied; values normalised to dollars), the share count from the company's latest 10-K/10-Q XBRL cover page, and Schedule 13D/13G filings. Each row is a legal 13F filer as filed — related entities (e.g. Vanguard's advisers) are not merged. Retail brokerage accounts are not reported on 13F, so the remainder is mostly retail and insiders.